Predictive Factors for Survival in Aggressive Meningiomas — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Predictive Factors for Survival in Aggressive Meningiomas — Stella

Recruiting

Back to Meningioma trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Italy

Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome

Key details

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Enrollment target

~250 participants

Started

January 2021

Primary completion

January 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated March 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov